NOVEMB

ER IS

LUNG CANCER AW

AR

EN

ESS MONTH

NOV 16

2018

Register at: https://cme.uchicago.edu/CLCU2018

CONFERENCE CO-DIRECTORSJyoti Patel, MD Everett Vokes, MD

676 North Michigan Avenue Chicago, IL 60611

OMNI HOTEL

CHICAGO LUNG CANCER UPDATES 2018

NEW PROGRAM!

NOV 16

2018

CONFERENCE DESCRIPTION

This educational program will inform clinicians on new therapeutic options and medical advances for the treatment of lung cancer that can be implemented in an effort to reduce lung cancer related deaths. It will provide physicians and other healthcare professionals

with new information that will improve their competence and ultimately improve patient

outcomes. By providing important therapeutic and standard of care developments, this

conference will educate oncologists on best practices for treating the disease.

TARGET AUDIENCEThis activity has been designed for physicians and other healthcare professionals interested in the prevention and treatment of lung cancer.

LEARNING OBJECTIVESAt the conclusion of this education activity, participants will be able to:

• Describe the appropriate selection of diagnostic modalities in the workup of a patient with suspected lung cancer

• Identify how to evaluate patients with malignant airway obstruction, mediastinal/hilar adenopathy, and peripheral lung lesions

• Understand the role of surgical resection for the treatment of locally advanced and oligometastatic lung cancer

• Understand the role of multidisciplinary evaluation of NSCLC patients

• Discuss novel non-invasive strategies for detection of lung cancer

• Understand the relevance of genotyping in NSCLC treatment and identification of targetable oncogenes

• Explain approach to oncogene addicted lung cancers and the role of sequencing targeted approaches

• Report key clinical trial findings on the use of immunotherapeutic strategies in locally advanced and advanced NSCLC

• Understand the role of immunotherapy in advanced NSCLC

• Identify emerging therapies for SCLC

• Understand the state of the art in radiation therapy for NSCLC brain metastases

• Discuss the side effects associated with new chemotherapeutic, targeted, and immunotherapy agents and their management

ACCREDITATION AND CREDIT DESIGNATIONThe University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

LOCATION/ACCOMMODATIONSThe conference will be held at the Omni Chicago Hotel, located at 676 North Michigan Avenue. The only all-suite luxury accommodations on Michigan Avenue are now even better! Embracing the iconic architecture within Chicago, the redesign highlights historical elements of Louis Sullivan’s intricate sketches, the Chicago School’s building materials and the whimsy of modern sculptures synonymous with the city.

We are pleased to offer a special discounted rate for conference attendees. The special rates start at $235.

Reservations for the UChicago Chicago Lung Cancer Updates 2018 conference must be received by the hotel no later than November 1, 2018 to guarantee this special rate.

• Call: 312.266.3014 and ask for Amanda Byrd (Amanda.Byrd@omnihotels.com)

CONFERENCE PARKING Parking is available at the Omni Hotel for $27 per car up to 12 hours.

* All rates are subject to state and city taxes. All reservations must be secured via a valid major credit card. Check-in time is 3 pm and check-out time is 12 pm.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

CONFERENCE FACULTY

Course Directors

University of Chicago Speakers Panel Discussants

Christine Bestvina, MDAssistant Professor (Hematology/Oncology)

Michael Bishop, MDProfessor (Hematology/Oncology)

Steven Chmura, MD, PhD Associate Professor of Radiation and Cellular Oncology

Jessica Donington, MD Professor of Surgery (Thoracic Surgery)

Thomas Hensing, MDClinical Associate Professor (Hematology/Oncology)

Philip Hoffman, MDProfessor of Medicine (Hematology/Oncology)

D. Kyle Hogarth, MDAssociate Professor of Medicine

Pulmonary/Critical Care

Heber MacMahon, MBProfessor of Radiology & Chief, Thoracic Radiology

Lauren L. Ritterhouse, MD, PhDAssistant Professor of Pathology

Co-Director, Division of Genomic & Molecular Pathology

Ralph Weichselbaum, MDD.K. Ludwig Professor of Radiation and Cellular Oncology Chair, Department of Radiation and Cellular Oncology

Brittany Beach, PAPhysician Assistant

Livia Szeto, RNResearch Nurse Associate

Invited Speakers

Hossein Borghaei, DO, MSChief, Division of Thoracic Medical Oncology

Associate Professor, Department of Hematology/Oncology

Fox Chase Cancer Center Temple University

Mary Jo J. Fidler, MDAssociate Professor Medical Oncology Rush Medical Center

Shirish M. Gadgeel, MDMary Lou Kennedy Research Professor in Thoracic Oncology

Professor, Department of Internal Medicine, Division of Hematology/Oncology

University of Michigan

Nisha Mohindra, MDAssistant Professor of Medicine Hematology & Medical Oncology Northwestern University

Jyoti Patel, MDProfessor of Medicine University of Chicago

Director of Thoracic Oncology, University of Chicago Medicine

Everett E. Vokes, MDJohn E. Ultmann Professor

Chairman, Department of Medicine

Physician-in-Chief, University of Chicago Medicine & Biological Sciences

DISCLOSURE DECLARATIONSAs a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine, asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine, requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

CLI

P H

ER

E T

O M

AIL

IN R

EG

ISTR

ATI

ON

FO

RM

✁

Conference Agenda - 2018CONFERENCE AGENDA

FRIDAY, NOVEMBER 16, 2018

7:00 a.m. PRE-TEST AND REGISTRATION

Session 1: Lung Cancer Immunotherapy, New Challenges/Frontiers

8:00 Welcome and Introductions Jyoti Patel, MD

8:05 First-Line Immunotherapy (Single agent, IO Doublets) Shirish M. Gadgeel, MD

8:30Immunotherapy in Early Stage and Locally Advanced Disease Everett E. Vokes, MD

8:50 Managing irAEs Christine Bestvina, MD

9:05Panel: Crossfire/Clinical Pearls Drs. Vokes, Bestvina, Patel and Gadgeel

9:35 BREAK

Session 2: Advances in Multidisciplinary Care of the Lung Cancer Patient

10:00 Radiology Updates (Nodules, GGOs) Heber MacMahon, MB

10:15 Pulmonary Updates (Peripheral Nodules, EBUS) D. Kyle Hogarth, MD

10:35 Surgery in the Era of Immunotherapy Jessica Donington, MD

11:00 Updates in Radiation Oncology Steven Chmura, MD

11:20 Evolving Role of Molecular Pathologist Lauren L. Ritterhouse, MD, PhD

11:40 Panel/Interactive Cases: All Speakers + Jyoti Patel, MD; Livia Szeto, RN; Brittany Beach, PA

12:10 p.m. LUNCH

Session 3: Mutation-Independent Therapy

1:00 First Line for PDL-1 Negative and Non-Oncogene Addicted Lung Cancer Hossein Borghaei, MD

1:20 Updates on Antiangiogenic Agents Thomas Hensing, MD

1:35 Treatment of Oligometastatic Disease Ralph Weichselbaum, MD

1:55 Advances in SCLC Jyoti Patel, MD

2:15 Panel: How I Treat Panel + Drs. Donington, Chmura and Brittany Beach; Livia Szeto, RN

2:45 BREAK

Session 4: Advances in Molecular-Based Therapy

3:00 Changes in the Landscape of EGFR-TKIs. Front Line and Beyond Christine Bestvina, MD

3:20 Sequencing of ALK Inhibitors Mary Jo Fidler, MD

3:35 BRAF Positive NSCLC Philip Hoffman, MD

3:40 Emerging Targets (ROS1, NTRK, Met, Her2) Nisha Mohindra, MD

3:55 Panel: Challenging Cases in Oncogene Addicted NSCLC Panel + Drs. Ritterhouse and Chmura

Session 5: Cellular Therapies Michael Bishop, MD

4:45 POST-TEST

5:00 ADJOURN

REGISTRATION INFORMATION

Fee

Physicians $150

Trainees and Nurses $30

Payment Total: $

PaymentHow To Register

ONLINE https://cme.uchicago.edu/CLCU2018 (credit card payment only)

To pay by check, you must mail this registration form with payment to:

MAIL The University of Chicago Center for Continuing Medical Education c/o Chicago Lung Cancer Updates 2018

5841 S. Maryland Ave., MC 1137 Chicago, IL 60637

Contact Information

Name  Degree

Specialty

Organization

Preferred Mailing Address

City  State  Zip

Phone  Fax

Email

In Case of Emergency

Please indicate any special needs

Please indicate any special dietary needs

Check enclosed (US funds only), payable to The University of Chicago (TID 36-2177139)

You must check this box if you do not want your mailing address shared with conference participants and/or

exhibitors (if applicable).

Please tell us how you found out about this activity, check all that apply:

Colleague   Save the Date  Brochure   Internet   Email

Journal Ad  Previous Attendance   Other

Cancellation PolicyIf you cancel your participation in this conference, your registration fee less a $25 administrative fee will be refunded

when written notification is received by October 15, 2018. No refunds will be made after November 1, 2018.

AccessibilityThe University of Chicago is committed to providing equal access appropriate to need and circumstance and

complies fully with the legal requirements of the Americans with Disabilities Act. If you are in need of special

accommodation, please contact our office at 773-702-1056 or via email at cme@bsd.uchicago.edu.

For additional information about this activity, please contact the Center for Continuing Medical Education at

773-702-1056.

CLI

P H

ER

E T

O M

AIL

IN R

EG

ISTR

ATI

ON

FO

RM

✁

The

Uni

vers

ity

of

Chi

cag

oC

ente

r fo

r C

ont

inui

ng M

edic

al E

duc

atio

n 58

41

S. M

aryl

and

Ave

., M

C 1

137

Chi

cag

o, I

L 6

06

37

Fri

day

, Nov

emb

er 1

6, 2

018

| O

mn

i Ho

tel

CH

ICA

GO

LU

NG

CA

NC

ER

U

PD

AT

ES

2018

NO

N-P

RO

FIT

OR

G.

US

PO

STA

GE

PA

IDL

AK

E F

OR

ES

T, IL

PE

RM

IT N

O. 7

9

NE

W P

RO

GR

AM

!

Lear

n ab

out

ne

w t

hera

peu

tic

o

pti

ons

and

m

edic

al

adva

nces

to

re

duc

e lu

ng

canc

er r

elat

ed

dea

ths

NO

VEMBER IS LUNG C

AN

CER

AWARENESS MO

NTH